What Researchers Did
Researchers conducted a controlled retrospective analysis of 196 patients with idiopathic sudden sensorineural hearing loss to compare the effectiveness of prostaglandin E1 plus hyperbaric oxygen therapy versus steroid plus hyperbaric oxygen therapy.
What They Found
Among 95 patients receiving prostaglandin E1 and 101 receiving steroids, both combined with hyperbaric oxygen, there were no significant differences in hearing recovery outcomes. For instance, cure rates were 28.4% for the prostaglandin E1 group and 28.7% for the steroid group, while recovery rates were 54.7% and 53.5%, respectively, indicating equal effectiveness.
What This Means for Canadian Patients
Canadian patients with idiopathic sudden sensorineural hearing loss may have an alternative treatment option if they cannot tolerate steroids. Prostaglandin E1 combined with hyperbaric oxygen therapy could be considered, especially for those with conditions like severe diabetes or peptic ulcers.
Canadian Relevance
This study has no direct Canadian connection as it was conducted outside of Canada.
Study Limitations
A limitation of this study is its retrospective design, which may be subject to selection bias and unmeasured confounding factors.